Examiner: PAGUIO FRISING, MICHELLE F

Tech Center 1700 • Art Units: 1626 1651 1732

This examiner grants 71% of resolved cases

Performance Statistics

70.8%

Allow Rate

+5.8% vs TC avg

601

Total Applications

+40.3%

Interview Lift

944

Avg Prosecution Days

Based on 572 resolved cases, 2023–2026

10.1%

§101 Eligibility

10.6%

§102 Novelty

35.1%

§103 Obviousness

23.4%

§112 Clarity

App #	Title	Status	Assignee
18552457	CATALYTICALLY INACTIVE CLOSTRIDIAL NEUROTOXINS FOR THE TREATMENT OF PAIN & INFLAMMATORY DISORDERS	Non-Final OA	IPSEN BIOPHARM LIMITED
18628290	Bile Acids and Use in Disease Treatment	Final Rejection	The Regents of the University of California
18718521	SGK1 INHIBITORY COMPOSITIONS AND METHODS	Non-Final OA	Arizona Board of Regents on Behalf of the University of Arizona

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.